Has it not occurred to anyone else that quite possibly further assays have been received from the lab reinforcing today's announcement.
Bearing in mind the board would have been crazy to not take up the strikeline option as it was and also allowing for the deadline being May 13.
My understanding and I can't recall who, however it was De Mori or Cronin, I think De Mori spent months and months looking for a suitable project and then weeks more negotiating with Thomas on the terms of the acquisition.
Being in Australia I doubt they could have found a better project to be involved in and perhaps they realised the benefits of operating in your own country as opposed to overseas, not with standing the success they had with ADT.
Just something to think about.
Cheers
TAR Price at posting:
9.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)